News Breaks |
|
|
| January 22, 2013 |
| 05:55 EDT |  | DNA, DNA, DNA, DNA, MNKD, MNKD, MNKD, MNKD, BMY, BMY, BMY, BMY, ARDM, ARDM, ARDM, ARDM, HGSI, HGSI, HGSI, HGSI, WST, WST, WST, WST, MEDI, MEDI, MEDI, MEDI | Cambridge Healthtech Institute to host a conference
12th Annual Pep Talk: Protein Science Week is being held in Palm Springs, California on January 21-25. |
|
|
News For DNA;MNKD;BMY;ARDM;HGSI;WST;MEDI From The Last 14 Days Check below for free stories on DNA;MNKD;BMY;ARDM;HGSI;WST;MEDI the last two weeks. |
|
|
| May 23, 2013 |
| 16:00 EDT |  | MNKD | Options Update; May 23, 2013
 Subscribe for More Information |
|
| 11:24 EDT | | MNKD | High option volume stocks: ZTS AMLP CTAS MNKD CYS
Subscribe for More Information |
|
| 09:59 EDT |  | MNKD | MannKind bucks general market downdraft, but falls from early highs
The stock was up sharply to $6.82, a new 52-week high, but has since fallen to $6.33. At that price, next support is at $6.23, the prior day close, and then at $6.05. Resistance is now at $6.54, the prior day high. |
|
| 06:02 EDT | | BMY | Bristol-Myers implied volatility at upper end of index mean range
|
|
| 05:49 EDT | | MNKD | Stocks with implied volatility movement; MNKD ORCL
Stocks with implied volatility movement; MannKind (MNKD), Oracle (ORCL) according to IVolatility. |
|
| 05:47 EDT | | BMY | Stocks with implied volatility movement; SKS BMY
Stocks with implied volatility movement; Saks (SKS), Bristol-Myers (BMY) according to IVolatility. |
|
| May 22, 2013 |
| 16:00 EDT | | MNKD, BMY | Options Update; May 22, 2013
Subscribe for More Information |
|
| 11:50 EDT | | MNKD | High option volume stocks: ZTS AIRM GLDD GTXI MNKD
Subscribe for More Information |
|
| 11:46 EDT | | MNKD | MannKind volatility elevated on sharp rally to 28-month high
Subscribe for More Information |
|
| 10:33 EDT |  | BMY | Bristol-Myers jumps after Citi ups rating on cancer potential
Subscribe for More Information |
| |
| 10:16 EDT | | BMY | Bristol-Myers spikes higher following upgrade, levels to watch
Subscribe for More Information |
|
| 10:00 EDT |  | BMY | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 06:05 EDT | | BMY | Bristol-Myers upgraded to Buy from Neutral at Citigroup
Subscribe for More Information |
|
| May 21, 2013 |
| 07:34 EDT | | BMY | UBS to host a conference
Subscribe for More Information |
|
| 07:24 EDT | | BMY | Global Health Care to host a conference
Subscribe for More Information |
|
| May 20, 2013 |
| 10:03 EDT | | BMY | Shire advances after report renews takeover speculation
Subscribe for More Information |
|
| 06:30 EDT |  | BMY | Leerink estimates Shire takeout value at least $110 per share
Leerink says a takeover price for Shire (SHPG) would need to be at least $110 per share in order to get the company's board to consider a sale. The firm notes a Daily Mail report last night said Bristol-Myers (BMY) has engaged advisors to study an acquisition of Shire and that Shire's CEO has contacted bankers to consider anti-takeover measures. Leerink believes a Bristol-Myers takeover of Shire would make sense and keeps an Outperform rating on Shire. |
|
| 06:25 EDT |  | BMY | Shire may return cash to thwart takeover, Daily Mail reports
Subscribe for More Information |
|
| May 17, 2013 |
| 13:21 EDT | | BMY | Options with increasing implied volatility: CPRT BMY GDI HNZ
Subscribe for More Information |
|
| 10:25 EDT | | MNKD | Summer Street says more optimistic on MannKind approval
Summer Street says it is more optimistic that the current trials of MannKind's inhalable insulin Afrezza could lead to FDA approval. The firm notes the product is completing two phase III trials and that it has been skeptical of approval in the past. Summer Street does not have an official rating on shares of MannKind, which are up 22c to $5.38 in early trading. |
| |
|
|
|
|
